evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract
5535,GENE_SUMMARY,,EP300 encodes a histone acetyltransferase that regulates transcription via chromatin remodelling. Loss of function mutations of EP300 are found in a diverse range of cancers.,,2017-04-26,,2033,EP300,E1A binding protein p300,False,ENST00000263253,NM_001429.3,p300,KAT3B,RSTS2,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5536,GENE_BACKGROUND,,"EP300 (p300; E1A-binding protein) is a transcriptional co-activator with histone acetyltransferase (HAT) activity that is homologous to the co-activator CREBBP. EP300 activates transcription by opening chromatin at gene promoters, recruiting transcriptional machinery and acting as a co-factor to recruit transcription factors (PMID: 15186775, 24480624, 11050151, 23474763, 15691758). The HAT activity of EP300 can also regulate the expression of other proteins, including the tumor suppressor p53 and tissue-specific transcription factors like GATA1 (PMID: 9830059, 9859997). Fusion proteins that include the EP300 HAT domain have been identified in rare cases of acute lymphoblastic leukemias (PMID: 25943178). Somatic mutations in EP300 are found in leukemia, lymphoma and solid tumors including small-cell lung cancer, cervical cancer and bladder cancer (PMID: 21390126, 22941188, 24390348, 21822268). EP300 mutations are commonly truncating and often co-occur with loss of the wildtype allele, suggesting that EP300 functions as a tumor suppressor. Small molecule inhibitors targeting EP300 have been found to be efficacious in preclinical and mouse studies (PMID: 26731516).",,2017-09-12,,2033,EP300,E1A binding protein p300,False,ENST00000263253,NM_001429.3,p300,KAT3B,RSTS2,True,15186775,"Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53.",Cell,2018-06-11T20:04:00,117,6,735-48,0001-01-08,,,0001-06-11,,9859997,Regulation of activity of the transcription factor GATA-1 by acetylation.,Nature,0001-12-10,396,6711,594-8,Boyes J et al,,,0001-12-10,,21390126,Inactivating mutations of acetyltransferase genes in B-cell lymphoma.,Nature,2018-03-10T20:11:00,471,7337,189-95,Pasqualucci L et al,doi: 10.1038/nature09730,,0001-03-10,,26731516,Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.,eLife,2018-01-05T20:16:00,5,,,Conery AR et al,pii: e10483. doi: 10.7554/eLife.10483,,0001-01-05,,9830059,Phosphorylation of p53 serine 15 increases interaction with CBP.,The Journal of biological chemistry,0001-12-04,273,49,33048-53,Lambert PF et al,,,0001-12-04,,22941188,Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.,Nature genetics,2018-10-01T20:12:00,44,10,1104-10,Peifer M et al,doi: 10.1038/ng.2396,,0001-10-01,,24390348,Landscape of genomic alterations in cervical carcinomas.,Nature,2018-02-20T20:14:00,506,7488,371-5,Ojesina AI et al,doi: 10.1038/nature12881,,0001-02-20,,11050151,Regulation of beta -catenin transformation by the p300 transcriptional coactivator.,Proceedings of the National Academy of Sciences of the United States of America,2018-11-07T20:00:00,97,23,12613-8,0001-01-07,,,0001-11-07,,21822268,Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.,Nature genetics,2018-08-07T20:11:00,43,9,875-8,Gui Y et al,doi: 10.1038/ng.907,,0001-08-07,,24480624,p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.,Cancer research,2018-03-15T20:14:00,74,6,1870-1880,Zhong J et al,doi: 10.1158/0008-5472.CAN-13-2485,,0001-03-15,,15691758,c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.,Developmental cell,2018-02-01T20:05:00,8,2,153-66,Sandberg ML et al,,,0001-02-01,,23474763,Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.,Oncogene,2018-02-20T20:14:00,33,8,1037-46,Xie X et al,doi: 10.1038/onc.2013.25,,0001-02-20,,25943178,A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.,Leukemia,2017-12-01T20:15:00,29,12,2445-8,Gocho Y et al,doi: 10.1038/leu.2015.111,,0001-12-01,
